PRESENTATION · Sep 2025 · PDF
Science
Explore conditions, clinical trials, and the latest research.
These pages contain non-exhaustive scientific information about uses of products that have not yet been approved by regulatory authorities, as their efficacy and safety for these uses have not yet been established. The information is provided for educational and scientific exchange purposes, and does not suggest products should be used in a manner not consistent with their respective label approved by the regulatory authorities, which may differ by geography. Any publication reflects the state of knowledge at the time it was published. The information is not medical advice and cannot replace the independent medical judgement of a healthcare professional.
PRESENTATION · Jul 2025 · PDF
ADH1 - ENDO 2025 - Baseline Characteristics of Pediatric Participants in the CLARIFY Disease Monitoring Study
PRESENTATION · Jul 2025 · PDF
Encaleret - ADH1 - ENDO 2025 - Phase 2 Over 42 Months Data Results
PRESENTATION · Jul 2025 · PDF
Encaleret - ADH1 - ENDO 2025 - CALIBRATE-PEDS Phase 2/3 Study Design
PRESENTATION · Dec 2024 · PDF
Encaleret - ADH1 - ASBMR 2024 Phase 2B Data over 24 Months
PRESENTATION · Dec 2024 · PDF
Encaleret - ADH1 - ASBMR 2024 Preliminary Findings from Ongoing Open Label Phase 2 Study
PRESENTATION · Dec 2024 · PDF
ADH1 - ENDO 2024 Characteristics of Adults with ADH1 enrolled in CLARIFY
PRESENTATION · Dec 2024 · PDF